Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 92%
filed 2026-07-17
Item 5.02
Chiyuan Deng, the Company's President and sole director, was appointed as Interim Chief Executive Officer and Interim Chief Financial Officer effective July 17, 2026. The principal disclosed action is a person taking on new executive roles (CEO and CFO), even though these are interim positions and he retains his existing President title under his existing Employment Agreement. The appointment of a sole director to dual interim C-suite roles is material to investors assessing leadership and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-17
Item 5.02
Jon S. Cummings IV was appointed Chief Executive Officer, Treasurer, Secretary, and sole Director of Londax Corp. effective July 13, 2026, coinciding with the change of control transaction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-16
Item 5.02
The filing discloses the appointment of Carrie R. Locklin, age 52, as Chief Financial Officer of Union Bankshares, Inc. and Union Bank, effective July 15, 2026. While the disclosure also notes that Karyn J. Hale transitions from CFO to Chief Operating Officer, the principal action is Locklin's appointment to the CFO role. This is a material executive appointment affecting the registrant's senior financial leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
Item 5.02
The disclosure centers on the Board's appointment of two new Class II directors, Matthew Ritter and Kevin Turner, on July 13, 2026, to fill vacancies created by a board size increase. Both appointees have substantial executive and board experience (Turner was former COO of Microsoft; Ritter has 25+ years in finance and real estate), and their appointments are material to investors as they expand board composition and governance. The related-party transaction disclosure and committee assignments are ancillary to the principal event of their appointment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
Item 5.02
Sharath Cherian was appointed as Chief Executive Officer and President of Destiny Media Technologies effective July 15, 2026, replacing interim CEO Hyonmyong Cho who remains as Chairman. The appointment includes compensatory arrangements comprising a base salary of $240,000, performance bonus eligibility, and stock option grants totaling 482,000 shares.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
Item 5.02
Gevo appointed Todd Werpy, Ph.D. as a Class II director to its Board of Directors, effective August 20, 2026. Werpy brings extensive experience in sustainable technologies, R&D, manufacturing operations, and enterprise transformation. The appointment includes compensatory arrangements of an annual cash retainer of $85,000 and an equity grant valued at $94,500.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
Item 5.02
Gyre Therapeutics appointed three new directors to its Board effective August 1, 2026: Yue Xiong, Ph.D. as a Class I director, Maxwell Kirkby as a Class II director (also appointed to the Compensation Committee), and Claire Weston, Ph.D. as a Class III director (also appointed to the Audit Committee). This materially affects board composition and committee structure at the biopharmaceutical company.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-16
EX-99
The exhibit discloses the RBI-approved appointment of Mr. Rajiv Kumar as Part-time Chairman of HDFC Bank effective July 15, 2026, for a three-year term under Section 10B(1A)(i) of the Banking Regulation Act, 1949. This is a material executive appointment of a senior leadership position (Chairman) that would affect a reasonable investor's assessment of the bank's governance and leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
Item 5.02
The filing discloses both a departure (Helen Meates stepping down as CFO effective October 1, 2026) and an appointment (Arun Kalra appointed as CFO effective the same date). While both events occur, the principal disclosed action centers on the appointment of Kalra to the CFO role, with the departure framed as a transition. The filing emphasizes Kalra's qualifications, tenure at the firm since 2016, and the Board's confidence in his appointment, making the appointment the salient event.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-16
Item 5.02
The filing discloses the appointment of Jasper B. Sanfilippo, Jr. as Chief Executive Officer effective October 1, 2026, and Frank Pellegrino's appointment as President and Chief Financial Officer on the same date. While Jeffrey T. Sanfilippo's transition from CEO to Executive Chair is also mentioned, the principal disclosed actions are the two executive appointments to senior leadership roles, which would materially affect investor assessment of company leadership and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
Item 5.02
The filing discloses both a director departure (Minsok Pak's resignation on July 14, 2026) and a director appointment (Sudhanshu Priyadarshi's appointment on the same date to fill the vacancy). While both events occur, the substantive focus and disclosure detail center on the appointment of Priyadarshi, including his extensive background (CFO roles at Planet Fitness, KDP, Vista Outdoor; 14 years at PepsiCo), his committee assignments (Audit and Sustainability), and the Board's rationale for his selection. The appointment of a qualified director with significant finance and packaged-goods expertise is material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
Item 8.01
Michael Christenson was appointed as Chair of the Board on July 16, 2026, while continuing as CEO. Although Paul Zevnik's resignation as Board Chair is also disclosed, the principal action disclosed is Christenson's appointment to the Chair role, making this an executive appointment event. The consolidation of CEO and Chair roles in a single executive is material to governance structure and investor assessment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-16
The filing discloses the appointment of George O'Leary as Interim Chief Financial Officer effective July 13, 2026, along with concurrent departures of the prior CFO (Jeremy Daniel) and COO (Duncan McGillivray). While the filing contains multiple executive transitions, the principal disclosed action centers on the appointment of O'Leary to the CFO role with specific compensation terms ($15,000/month, 35,000 stock options vesting upon Nasdaq listing). This is material as it affects the registrant's senior financial leadership and governance structure.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 85%
filed 2026-07-16
The 6-K discloses the appointment of Bo Lyu as an independent director and member of three board committees (audit, compensation, nominating and corporate governance) effective July 1, 2026. While the report also mentions the concurrent resignation of Jean Christophe Baron Von Pfetten, the principal disclosed action is the appointment of Mr. Lyu to fill the vacancy. The filing includes detailed biographical information and confirms his independence under Nasdaq and SEC rules, indicating material governance significance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
Item 5.02
Andrew Jay Glashow was appointed as a Class I director and Chief Executive Officer of SpringBig Holdings, effective July 10, 2026, representing a material change in the Company's leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
Item 5.02
Effective immediately after the merger closing, Patrick Crutcher was appointed as a Class I director and Matthew Ros was appointed as Chief Operating Officer of the combined company. These appointments represent material forward-looking leadership changes tied to the merger transaction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
Item 5.02
Suchi Sastri was appointed as a Class III director effective July 14, 2026, and concurrently appointed to the Audit Committee, restoring the company's compliance with Nasdaq listing rules requiring three independent Audit Committee members.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
The filing discloses the appointment of Ryan Carver as Chief Development Officer of Soluna Holdings, effective immediately on July 16, 2026. Carver is a senior executive from Microsoft with extensive experience leading hyperscale AI data center construction programs, and will report directly to the CEO and sit on the Senior Leadership Team. This is a material executive appointment to a key operational leadership role.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
The filing discloses the election of Benjamin Buchanan as an independent director effective July 15, 2026, with appointment to the Audit Committee, Compensation Committee, and Nomination and Governance Committee. The appointment is material because it restores the Audit Committee to three members and brings the Company into compliance with Nasdaq Listing Rules 5605(c)(2)(A) and 5605(b), addressing prior governance deficiencies.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
The filing discloses two board appointments on July 15, 2026: Guibao Ji (the Company's CFO) and Alejandro Quiles, with Quiles designated as Compensation Committee chairman and determined to be independent under Nasdaq Rule 5605(a)(2). While the filing also mentions Chenlong Liu's resignation on July 10, the principal disclosed action centers on the two new director appointments and their committee assignments, making exec_appointment the most salient classification. The appointments are material to investors as they affect board composition and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
The filing discloses that on July 15, 2026, the board of directors appointed Michael Regan as Chief Operating Officer and Secretary of SHF Holdings, Inc. This is a clear executive appointment to a material officer position. The disclosure is made under Item 5.02, which covers both departures and appointments, and the principal action disclosed is the appointment of an officer to a senior operational role.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
Item 5.02
The filing discloses that Hayden Brown, the Company's President and CEO, has been appointed to assume the role of interim principal financial officer effective July 14, 2026, during CFO Erica Gessert's temporary medical leave. While the departure of the CFO is also mentioned, the principal disclosed action is the appointment of Brown to the interim CFO role. This is material because it involves a change in the principal financial officer position, a key executive role affecting investor confidence in financial reporting and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
Item 5.02
The filing discloses the appointment of Bobby L. Owens as General Counsel effective July 13, 2026, with detailed compensation terms including $325,000 base salary, 60% bonus target, $100,000 sign-on equity award, and severance provisions. While the section also mentions Jonathan Norling's termination as Chief Legal Officer, the principal disclosed action centers on the appointment of a new named executive officer with a comprehensive offer letter. The appointment of a General Counsel to lead the company's legal function is material to investors assessing management quality and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
Item 5.02
Christopher Peetz was appointed as a new member of the Board of Directors effective July 15, 2026, with the Board increasing authorized directors from nine to ten. Peetz brings extensive biopharmaceutical leadership experience, including his current CEO role at Mirum Pharmaceuticals, and received an initial stock option award of 21,486 shares plus prorated annual equity and cash retainer.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
Item 5.02
BuzzFeed appointed Stanley E. Washington as an independent director effective July 16, 2026, with assignment as Chair of the Compensation Committee. The appointment reflects a significant board composition change tied to the Allen Family Digital investment transaction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
Item 5.02
The filing discloses the appointment of two Class III directors, Justyn Feldman and Sanghyun Lee, to Douglas Elliman's Board effective July 10, 2026. The principal disclosed action is the taking of board roles by these individuals, making this an executive appointment event. Board composition changes are material to investors assessing governance and oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
American Airlines elected John W. Dietrich to its Board of Directors, assigning him to the Audit Committee and Finance Committee. Dietrich brings 35 years of aviation and financial leadership experience, including service as CFO of FedEx and President/CEO of Atlas Air, strengthening the company's governance and financial oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
Robert Osborn was appointed as Controller and principal accounting officer of AES Ohio on July 10, 2026, by unanimous Board consent. This is a material executive appointment to a principal accounting officer role, a position responsible for financial reporting and internal controls. The disclosure includes his background, qualifications, and compensation arrangements, consistent with Item 5.02(c) appointment disclosures.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
Robert Osborn was appointed as Controller and principal accounting officer of IPALCO and AES Indiana on July 10, 2026, by unanimous written consent of the Boards of Directors. This is a clear executive appointment to a principal accounting officer role, which is a material officer position. While Sherry Kohan's role was modified (retaining CFO but relinquishing Controller duties), the principal disclosed action is Osborn's appointment to the Controller position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
The Hartford Insurance Group, Inc. elected Randy Larsen as a director, effective September 1, 2026, with appointment to two board committees. Larsen is an experienced insurance-industry executive with 13 years at AssuredPartners (including CEO service) and 14 years at Schifman Remley & Associates. The appointment includes compensatory arrangements of $82,700 in cash retainer and $136,600 in RSU equity compensation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
The filing discloses the appointment of Brent MacDonald to Socket Mobile's Board of Directors effective July 13, 2026. MacDonald, who previously served on the Board from 2016 to 2023, has been reappointed as an independent director. This is a clear executive appointment event under Item 5.02, and the Board's determination of his independence status and standard director compensation arrangements are disclosed. The appointment is material as it affects the composition and governance of the company's board.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
The filing discloses the appointment of James H. Bradshaw as a member of RLI's Board of Directors, effective July 15, 2026, with assignment to the Audit and Finance & Risk Committees. The principal disclosed action is a person taking a role (board appointment), making this an exec_appointment event. The appointment of a director with significant industry experience (40+ years in insurance leadership) to key board committees is material to investors' assessment of governance and strategic direction.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 75%
filed 2026-07-15
EX-99.1
The exhibit discloses the appointment of Dr. Jeff Millard as Executive Vice President, Technical Operations effective July 13, 2026, and the elevation of Dr. Alex Therien to Executive Vice President, Research & Development. While the filing also mentions Amanda Malone's departure as Chief Scientific and Operating Officer, the primary announced action is the appointment of new executive leadership to support the company's clinical and commercial development. The material change report emphasizes these leadership updates as part of the company's evolution and operational restructuring.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
The filing discloses the appointment of Reza Zadno, Ph.D. as a new director to Mobia Medical's Board, increasing the Board size from six to seven members. Dr. Zadno was also appointed to the Compensation Committee as an independent director. This is a clear executive appointment event under Item 5.02(d), and is material as board composition changes affect corporate governance and investor assessment of the company's leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
Aziz Mottiwala was appointed as President and Chief Executive Officer effective July 20, 2026, replacing Ron Kurtz, M.D., who transitioned to Chief Medical Officer. Mottiwala was also appointed to the Board of Directors with detailed employment terms including $14 million in equity awards.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-07-15
EX-99.1
The press release announces the appointment of John M. Melkon to the board of directors of Skyline Builders Group Holding Limited, effective immediately. The disclosure also notes that Ngo Chiu Lam is stepping down from the board concurrently. The appointment of a director with significant expertise in critical materials supply chains and geopolitical operations is material to investors evaluating the company's strategic pivot from Asian construction to critical minerals supply, particularly given the pending merger with Cove Kaz and the company's stated objective to become a strategic supplier to the U.S. defense and industrial base.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-07-15
The 6-K discloses the appointment of Mr. Ning Xue as an independent director effective July 14, 2026, along with his appointment as Chairperson of the Nominating and Corporate Governance Committee and member of the Audit and Compensation Committees. While Dr. Jiayuan Tong's resignation is also mentioned, the principal disclosed action is the appointment of a new director to fill the vacancy, making this an exec_appointment event. The appointment includes detailed background on Mr. Xue's qualifications and compensation terms ($14,082 for the initial term).
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-15
EX-99.1
The press release announces the appointment of Rodrigo Natale as Chief Financial Officer of Nuvini Group Limited, effective July 20, 2026. This is a clear executive appointment of a named officer to a senior leadership role. The appointment is material because it fills a CFO vacancy that had existed since February 2026 (when Roberto Otero resigned) and restores dedicated financial oversight and governance to the company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 7.01
The filing announces the appointment of Michael Deal as Senior Vice President and Chief Operating Officer of Hycroft Mining, effective August 24, 2026. The press release (Exhibit 99.1) emphasizes his 20+ years of operating and technical leadership experience in gold and silver mining operations, his prior role at First Majestic Silver managing a $1 billion acquisition integration, and his direct relevance to Hycroft's strategy of advancing the Hycroft Mine. This is a material executive appointment to a senior operational leadership position.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-15
The 6-K discloses the appointment of three executives effective July 13, 2026: Ms. Chen Shulan as Executive Chairman and Director (with US$300,000 annual base compensation), Ms. Lim Hui Leng as independent Director and Audit Committee Chairman (US$20,000 annual fee), and Mr. Yuen Jia Feng Leonard as Chief Financial Officer (SGD 10,500 monthly salary). These are material leadership changes affecting the registrant's governance and financial oversight structure.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-15
The exhibit discloses the appointment of Mr Mark Hoffman as an independent non-executive director of DRDGOLD effective August 1, 2026. This is a clear executive/board appointment requiring disclosure under JSE Listings Requirements paragraph 6.71(a). The appointment of a director with significant professional credentials (Chartered Accountant, 35+ years in professional services, former Deloitte and KPMG partner) is material to investors' assessment of board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-15
Item 5.02
The filing discloses the appointment of John Markels to the Board as a Class II director effective July 16, 2026, with concurrent appointment to the Audit Committee and Compensation Committee. While the section also mentions Heath Lukatch's retirement, the principal disclosed action centers on the new director appointment and his committee assignments. Board composition changes are material to investors assessing governance and oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
Timothy Dugan was appointed to the Board of Directors of Infinity Natural Resources, Inc. effective July 13, 2026, to fill a current vacancy. The Board affirmatively determined his independence, and Dugan brings extensive executive leadership experience spanning four decades in the Appalachian energy industry, including prior roles as CEO and COO at major energy companies.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-14
Item 5.02
Britt Vitalone was appointed to Cheniere's Board of Directors effective July 14, 2026, with assignment to the Audit and Compensation Committees. Vitalone brings 30+ years of executive leadership experience, including his recent role as Executive Vice President and Chief Financial Officer at McKesson Corporation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-14
Item 5.02
Christian M. Lown was appointed as Executive Vice President and Chief Financial Officer of The Allstate Corporation, effective August 3, 2026. The appointment includes a base salary of $875,000, a sign-on bonus of $2,000,000, and equity grants. Lown brings 25+ years of senior leadership experience in finance and capital markets, including prior CFO roles at CoStar Group, Freddie Mac, and Navient Corporation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-14
Item 5.02
Kelly E. Garcia was appointed as Chief Technology Officer of Ulta Beauty, effective August 31, 2026, bringing more than 25 years of leadership experience in e-commerce, customer loyalty, digital innovation, and cybersecurity to support the company's technology strategy.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-07-14
The 6-K discloses the appointment of two new directors effective July 10, 2026: Ms. Mei Ting Yeung (appointed as director, Chair of the Audit Committee, and committee member) and Mr. Wei Li (appointed as director and committee member). While the filing also mentions two concurrent resignations, the principal disclosed action is the appointment of these new board members with detailed biographical information and committee assignments. The appointments are material to investors as they affect board composition and audit committee leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-14
Item 5.02
Zachary F. Sadek was appointed to the Board of Directors effective July 13, 2026, pursuant to a Cooperation Agreement with PCP Managers II, L.P. (Parthenon Capital), one of the Company's largest stockholders, expanding the board from six to seven members.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-14
Item 5.02
Alan Musso and John Maslowski were appointed to the Board of Directors effective July 10, 2026, in connection with the Company's IPO, with concurrent appointments to the Audit, Nominating, and Compensation committees.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-14
Item 5.02
The Board appointed two new directors, Christopher Riccardi and Greg Voorhies, effective July 11, 2026, with terms expiring at the 2028 annual meeting. This is a clear director appointment disclosure under Item 5.02, and director appointments are material events affecting the composition and governance of the company's board.
View raw filing on EDGAR →